LENTIVIRAL-MEDIATED GENE THERAPY FOR SEVERE PYRUVATE KINASE DEFICIENCY: RESULTS FROM AN ONGOING GLOBAL PHASE 1 STUDY

被引：0

作者：

Lopez Lorenzo, Jose Luis ^{[1
,2
]}

Shah, Ami ^{[3
]}

Sevilla, Julian ^{[5
,6
]}

Navarro, Susana ^{[2
,6
,7
]}

Llanos, Lucia ^{[1
,2
]}

de Camino Gaisse, Begona Perez ^{[1
,2
]}

Sanchez, Sol ^{[1
,2
]}

Zubicaray, Josune ^{[5
]}

Glader, Bertil ^{[3
,4
]}

Chien, May ^{[3
,4
]}

Quintana Bustamante, Oscar ^{[2
,6
,7
]}

Zeini, Miriam ^{[8
]}

Choi, Grace ^{[8
]}

Nicoletti, Eileen ^{[8
]}

Rao, Gayatri ^{[8
]}

Roncarolo, Maria Grazia ^{[3
,4
]}

Bueren, Juan ^{[2
,6
,7
]}

Schwartz, Jonathan ^{[8
]}

Carlos Segovia, Jose ^{[2
,6
,7
]}

机构：

[1] Hosp Univ Fdn Jimenez Diaz, Madrid, Spain

[2] Inst Invest Sanitaria Fdn Jimenez Diaz IIS FJD, Madrid, Spain

[3] Stanford Univ, Sch Med, Stanford, CA USA

[4] Lucile Packard Childrens Hosp, Palo Alto, CA USA

[5] Hosp Infantil Univ Nino Jesus HIUNJ, Fdn invest Biomed, Madrid, Spain

[6] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain

[7] Ctr Invest Energet Medioambientales & Tecnol CIEM, Madrid, Spain

[8] Rocket Pharmaceut Inc, Cranbury, NJ USA

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P181

引用

页码：275 / 276

页数：2

共 50 条

[31] Lentiviral-mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Results from Global RP-L102 Clinical Trials
Sevilla, J.
Czechowicz, A.
Booth, C.
Agarwal, R.
Zubicaray, J.
Rio, P.
Navarro, S.
Chetty, K.
O'Toole, G.
Xu-Bayford, J.
Ancliff, P.
Sebastian, E.
Choi, G.
Zeini, M.
Nicoletti, E.
Wagner, J. E.
Rao, G. R.
Thrasher, A. J.
Schwartz, J. D.
Roncarolo, M. G.
Bueren, J. A.
HUMAN GENE THERAPY, 2022, 33 (23-24) : A61 - A61
[32] Preclinical safety and efficacy of lentiviral-mediated gene therapy for leukocyte adhesion deficiency type I
Mesa-Nunez, Cristina
Damian, Carlos
Fernandez-Garcia, Maria
Diez, Begona
Rao, Gayatri
Schwartz, Jonathan D.
Law, Ken M.
Sevilla, Julian
Rio, Paula
Yanez, Rosa
Bueren, Juan A.
Almarza, Elena
MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2022, 26 : 459 - 470
[33] Development and Validation of a GMP Grade Lentiviral Vector for the Gene Therapy of Pyruvate Kinase Deficiency
Navarro, Susana
Trigueros, Cesar
Quintana-Bustamante, Oscar
Villanueva, Mariela S.
Lopez-Manzaneda, Sergio
Bueren, Juan A.
Ramirez, Juan C.
Segovia, Jose C.
MOLECULAR THERAPY, 2017, 25 (05) : 126 - 126
[34] LENTIVIRAL-MEDIATED GENE THERAPY FOR PATIENTS WITH FANCONI ANEMIA [GROUP A]: UPDATED RESULTS FROM GLOBAL RP-L102 CLINICAL TRIALS
Sevilla, Julian
Booth, Claire
Czechowicz, Agnieszka
Agarwal, Rajni
Zubicaray, Josune
Rio, Paula
Chetty, Kritika
O'Toole, Grainne
Xu-Bayford, Jinhua
Ancliff, Philip
Sebastian, Elena
Choi, Grace
Zeini, Miriam
Nicoletti, Eileen
Eide, Cindy
Wagner, John
Rao, Gayatri
Thrasher, Adrian
Schwartz, Jonathan
Roncarolo, Maria Grazia
Bueren, Juan
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 276 - 277
[35] Lentiviral-Mediated Gene Therapy for Patients with Fanconi Anemia [Group a]: Updated Results from Global RP-L102 Clinical Trials
Czechowicz, Agnieszka D.
Sevilla, Julian
Booth, Claire
Zubicaray, Josune
Rio, Paula
Navarro, Susana
Cherry, Kritika
O'Toole, Grainne
Xu-Bayford, Jinhua
Ancliff, Philip
Sebastian, Elena
Rothe, Michael
Bastone, Antonella L.
John-Neek, Philipp
Schambach, Axel
Wang, Wei
Choi, Grace
Zeini, Miriam
Nicoletti, Eileen
Eide, Cindy
Wagner, John E.
Rao, Gayatri R.
Thrasher, Adrian J.
Roncarolo, Maria-Grazia
Schwartz, Jonathan
Bueren, Juan A.
Agarwal, Rajni
BLOOD, 2024, 144 : 7463 - 7464
[36] Lentiviral-mediated Gene Therapy for Patients with Fanconi Anemia [Group A]: Updated Results from Global RP-L102 Clinical Trials
Czechowicz, Agnieszka
Sevilla, Julian
Booth, Claire
Agarwal, Rajni
Zubicaray, Josune
Rio, Paula
Navarro, Susana
Chetty, Kritika
O'Toole, Grainne
Xu-Bayford, Jinhua
Ancliff, Philip
Sebastian, Elena
Choi, Grace
Zeini, Miriam
Nicoletti, Eileen
Wagner, John E.
Rao, Gayatri R.
Thrasher, Adrian J.
Schwartz, Jonathan D.
Roncarolo, Maria Grazia
Bueren, Juan A.
BLOOD, 2022, 140 : 10646 - 10647
[37] OPTIMIZATION OF TRANSDUCTION CONDITIONS WITH GMP LIKE LENTIVIRAL VECTORS FOR THE GENE THERAPY OF PYRUVATE KINASE DEFICIENCY
Navarro, S.
Quintana-Bustamante, O.
Trigueros, C.
Villanueva, M.
Lopez-Manzaneda, S.
Bueren, J. A.
Ramirez, J. C.
Segovia, J. C.
HAEMATOLOGICA, 2017, 102 : 451 - 452
[38] Development of Tissue-Specific Lentiviral Vectors for the Gene Therapy of the Erythroid Pyruvate Kinase Deficiency
Garcia-Gomez, M.
Meza, N. W.
Navarro, S.
Alonso-Ferrero, M. E.
Bueren, J. A.
Segovia, J. C.
HUMAN GENE THERAPY, 2009, 20 (09) : 1091 - 1091
[39] Tissue-Specific Lentiviral Vectors as a Tool for the Gene Therapy of the Erythroid Pyruvate Kinase Deficiency
Garcia-Gomez, Maria
Meza, Nestor W.
Navarro, Susana
Alonso-Ferrero, Maria E.
Bueren, Juan A.
Segovia, Jose C.
MOLECULAR THERAPY, 2009, 17 : S119 - S120
[40] An Ongoing Global, Longitudinal, Observational Study of Patients with Pyruvate Kinase Deficiency: The PEAK Registry
Grace, Rachael F.
Bianchi, Paola
Glader, Bertil
Glenthoj, Andreas
Jones, Bryan
Kanno, Hitoshi
Kuo, Kevin H. M.
Layton, D. Mark
van Beers, Eduard J.
Corrons, Joan-Lluis Vives
Xu, Tu
BLOOD, 2019, 134

← 1 2 3 4 5 →